know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

CEU 2024 Runs Through Saturday

September 20, 2024

Clinical Endocrinology Update (CEU) 2024 runs September 19 - 21. This is your final opportunity to gain insights from top experts on the latest advancements in endocrinology. The program includes sessions on adrenal care, diabetes, obesity, thyroid disorders, bone and calcium care, reproductive endocrinology, and more. Don’t miss this chance to enhance your practice with actionable knowledge and earn 27 AMA PRA Category 1 Credits™ and 6.75 ABIM MOC Points. Register now!

Membership

Join Today, Stay Informed Tomorrow

September 11, 2024

Join the Endocrine Society by Monday, September 30 to receive member discounts and gain access to exclusive resources through December 2025. Once a member, you will qualify for discounts through 2024 and all of 2025. Stay current on the latest in endocrinology with some of the top resources in our field.

Board Review

Just Released: Endocrine Board Review Book - 16th Edition (2024)

September 18, 2024

Get ready for your endocrine board exams with the Endocrine Board Review 16th (2024) Edition book. Featuring 221 clinical case questions that cover the full range of endocrinology, this book is aligned with the American Board of Internal Medicine’s (ABIM) Endocrinology, Diabetes, and Metabolism exam to test and expand your knowledge. Order Now!

Meetings & Events

Artificial Intelligence in Healthcare Early Rates Extended

September 03, 2024

Early registration rates for our AI in Healthcare Virtual Summit have been extended. Register by Monday, September 30 at 11:59 PM ET to secure the lowest possible rates. This innovative two-day virtual event features presentations from the leading minds in AI and healthcare, offering providers and researchers a unique opportunity to delve into the future of AI and medicine.

Advocacy

Advocacy in Action

September 20, 2024

Read about the Society's latest advocacy efforts to protect biomedical research funding and learn the latest happenings on Capitol Hill regarding access to care.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Moderate coffee consumption is associated with lower risk of developing multiple cardiometabolic diseases

September 17, 2024

Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Girls may start puberty early due to chemical exposure

September 10, 2024

Girls exposed to certain endocrine-disrupting chemicals (EDCs) may be more likely to start puberty early, according to new research published in Endocrinology, the flagship basic science journal of the Endocrine Society. EDCs mimic, block or interfere with hormones in the body's endocrine system.

Pregnant women exposed to PFAS may be at risk for obesity, heart disease later in life

September 05, 2024

Women with higher levels of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems later in life, according to new research published in The Journal of Clinical Endocrinology & Metabolism.

View More

Featured Journal Articles

JCEM Case Reports: An Opportunity Not to Be Missed

September 17, 2024

At the June 2024 Annual Endocrine Society Meeting in Boston (ENDO2024), we celebrated our first 18 months of publication by hosting our second annual symposium entitled “Clinical Pearls from JCEM Case Reports.”

Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer

September 17, 2024

This study elucidates the critical role of progesterone receptor signaling in mediating the protumorigenic effects of cancer-associated fibroblasts on estrogen receptor-positive luminal breast cancer cells.

Cardiometabolic Risk Markers in Children With Obesity and Variants in MC4R Pathway-Related Genes

September 17, 2024

We compared the severity of obesity and cardiometabolic risk markers in children with MC4R pathway-related clinically reported genetic variants relative to children without these variants.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.